Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Radjak launches rapid cardiac, stroke unit for urban emergencies 2. Construction underway on Laos’ first national university hospital 3. Bayside Health begins operations in Victoria, Australia 4. How will US tariffs affect Singapore’s biomedical sector? 5. Northern Beaches Hospital to join NSW public health systemResource Center
Read Here
Advertise
Sign Up
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
